Capital Firms
Selected Capital Firm News
William Blair
William Blair Sticks to Their Buy Rating for Viking Therapeutics (VKTX) | 9/12/2020
William Blair Sticks to Their Buy Rating for Viking Therapeutics (VKTX) Austin Angelo - September 11, 2020, 5:15 PM EDT SHARE ON: William Blair analyst Andy Hsieh maintained a Buy rating on Viking Therapeutics ( VKTX ) on September 9. The company’s shares closed last Friday at $5.73. According to TipRanks.com , Hsieh is a 4-star analyst with an average return of 14.8% and a 58.1% success rate. Hsieh covers the Healthcare sector …
BlackRock Inc.
Cheviot Value Management LLC Sells 3,775 Shares of CVS Health Corp (NYSE:CVS) | 9/12/2020
… period. Cheviot Value Management LLC’s holdings in CVS Health were worth $1,805,000 at the end of the most recent reporting period. Several other hedge funds have also made changes to their positions in CVS. BlackRock Inc. lifted its holdings in CVS Health by 1.3% during the 2nd quarter. BlackRock Inc. now owns 97,156,370 shares of the pharmacy operator’s stock worth $6,312,247,000 after purchasing an additional 1,281,119 shares during the last …
Cantor Fitzgerald
Where I Was on September 11, 2001 | 9/12/2020
… constantly, especially around this time each year. And it’s important to me that I share them with you. By Jason Bodner, editor, Palm Beach Insider 9/11. 19 years ago today. I’d started working at Cantor Fitzgerald just five weeks earlier. And I spent a month in the North Tower of the World Trade Center. I would show up to work at 7:15 a.m. and take the three elevator rides to …
Baxter International
Canada Pension Plan Investment Board reduced its position in Baxter International Inc (NYSE:BAX) by 46.3% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 470,748 shares of the medical instruments supplier’s stock after selling 405,697 shares during the period. Canada Pension Plan Investment Board owned approximately 0.09% of Baxter International worth $40,531,000 as of its …
Zacks Investment Research
TherapeuticsMD (NASDAQ:TXMD) Shares Down 5.7% | 9/11/2020
… for the stock from $1.25 to $1.20 in a research note on Friday, August 7th. BidaskClub lowered TherapeuticsMD from a “hold” rating to a “sell” rating in a research note on Saturday, August 29th. Zacks Investment Research lowered TherapeuticsMD from a “hold” rating to a “sell” rating in a research note on Saturday, August 1st. Noble Financial restated a “buy” rating and issued a $10.00 target price on shares of …
Geode Capital Management
Great Point Partners LLC Trims Stake in Acceleron Pharma Inc (NASDAQ:XLRN) | 9/11/2020
… Great Point Partners LLC’s holdings in Acceleron Pharma were worth $5,531,000 as of its most recent SEC filing. A number of other institutional investors have also recently bought and sold shares of the stock. Geode Capital Management LLC grew its stake in Acceleron Pharma by 6.7% in the 1st quarter. Geode Capital Management LLC now owns 682,845 shares of the biopharmaceutical company’s stock worth $61,367,000 after acquiring an additional 43,011 …
Bain Capital
Earnings this week : September 7 - 11, 20 (wk 37) | 9/11/2020
… sales ATHM ATHN ATI ATPG ATRS ATVI ATW AU auto dealerships AUY AVGO AVLR AVP AVTR AVXS AVYA AWK AXAHY AXGN AXL AXLL AXON AXP AYX AZN AZO AZUL BA BABA BABY BAC BAH Bain Capital BAM BANC bankruptcies Barrick Gold (GOLD) Barron’s BATS BAX Bayer BB BBBY BBG BBQ BBRY BBT BBW BBY BC Partners BCH BCRX BCS BDX BE bear trap bearish signals BEBE BEN best trades BETR …
Social Capital
Report: One of Social Capital’s newest blank-check companies is looking to reverse merge with Opendoor Connie Loizos @Cookie / 1 day Some people may have slowed down in 2020, amid a pandemic that has shut down much of the world. Not Chamath Palihapitiya . According to a new report in Bloomberg , Opendoor, the San Francisco-based company that aims to help people buy and sell homes with the “push of a …
SunTrust Banks
… report on Wednesday, September 2nd. Mizuho cut their price objective on Walgreens Boots Alliance from $48.00 to $43.00 and set a neutral rating for the company in a research report on Tuesday, July 21st. SunTrust Banks cut their price objective on Walgreens Boots Alliance from $42.00 to $40.00 and set a hold rating for the company in a research report on Friday, July 10th. Morgan Stanley cut their price objective …
Citigroup
EJF Capital LLC Makes New Investment in Independence Holding (NYSE:IHC) | 9/10/2020
… Independence by 56.3% in the second quarter. Bank of Montreal Can now owns 1,010 shares of the financial services provider’s stock valued at $28,000 after purchasing an additional 364 shares in the last quarter. Citigroup Inc. lifted its holdings in shares of Independence by 31.7% in the first quarter. Citigroup Inc. now owns 1,545 shares of the financial services provider’s stock valued at $39,000 after purchasing an additional 372 shares …
Redmile Group
… stake in shares of 1life Healthcare during the 1st quarter valued at approximately $511,062,000. Maverick Capital Ltd. acquired a new stake in shares of 1life Healthcare during the 1st quarter valued at approximately $101,486,000. Redmile Group LLC acquired a new stake in shares of 1life Healthcare during the 1st quarter valued at approximately $56,689,000. FIL Ltd lifted its position in shares of 1life Healthcare by 99.0% during the 2nd quarter …
Sands Capital
Point72 Hong Kong Ltd Invests $2.94 Million in Zoetis Inc (NYSE:ZTS) | 9/10/2020
… of Zoetis by 6,026.7% in the second quarter. Copper Rock Capital Partners LLC now owns 8,331,273 shares of the company’s stock valued at $1,081,569,000 after buying an additional 8,195,290 shares during the last quarter. Sands Capital Management LLC raised its position in shares of Zoetis by 7.9% in the first quarter. Sands Capital Management LLC now owns 6,007,652 shares of the company’s stock valued at $707,041,000 after buying an additional …
Stryker
Stamos Capital Partners L.P. Lowers Position in Stryker Co. (NYSE:SYK) | 9/10/2020
Stamos Capital Partners L.P. lessened its position in Stryker Co. (NYSE:SYK) by 81.5% in the second quarter, according to the company in its most recent filing with the Securities& Exchange Commission. The firm owned 1,200 shares of the medical technology company’s stock after selling 5,286 shares during the quarter. Stamos Capital Partners L.P.’s holdings in Stryker were worth $216,000 as of its most recent filing with the Securities …
Khosla Ventures
… food tech startup was founded in 2011 by Patrick O. Brown, M.D., Ph.D., Professor Emeritus of Biochemistry at Stanford University and a former Howard Hughes Medical Institute investigator. Investors include Mirae Asset Global Investments, Khosla Ventures , Bill Gates, Google Ventures, Horizons Ventures, UBS, Viking Global Investors, Temasek, Sailing Capital, and Open Philanthropy Project. Impossible Foods was Inc. Magazine’s company of the year and one of Time Magazine’s 50 Genius companies …
Blackstone Group
Pcysys Raises $25M in Series B Funding | 9/10/2020
By FinSMEs Pcysys , a Tel-Aviv, Israel-based cybersecurity validation company, completed a $25m Series B funding. The round was led by Insight Partners, along with existing investors, Awz Ventures and The Blackstone Group . The company, which has raised $40m to date, intends to use the funds to expand its sales and delivery teams in North America, EMEA, and Asia Pacific as well as continue the development of its technology …
Fidelity Investments
The 2-Minute Rule for estate planning | 9/10/2020
… your parent to call a guardian to deal with a kid if a little something were being to happen towards the mum or dad,” suggests Sander Bleustein, vice president of Highly developed Planning at Fidelity Investments . “But, whilst naming a guardian is vital, It truly is only one action.Even so, you are still Blessed for until now, you are still there striving to really make it progressive and successful. But …
Pinnacle Financial Partners
Wall Street analysts predict that Pinnacle Financial Partners (NASDAQ:PNFP) will announce $1.01 earnings per share (EPS) for the current quarter, according to Zacks . Four analysts have provided estimates for Pinnacle Financial Partners’ earnings, with estimates ranging from $0.60 to $1.29. Pinnacle Financial Partners reported earnings of $1.44 per share in the same quarter last year, which would indicate a negative year over year growth rate of 29.9%. The business …
Carlyle Group
The Carlyle Group Inc. – Consensus Indicates Potential 19.8% Upside | 9/10/2020
The Carlyle Group Inc. with ticker code (CG) now have 15 analysts in total covering the stock. The consensus rating is ‘Hold’. The target price ranges between 40 and 27 calculating the mean target price we have 30.93. Given that the stocks previous close was at 25.82 this indicates there is a potential upside of 19.8%. The 50 day moving average now sits at 27.45 and the 200 moving average …
Principal Financial Group
PTC Therapeutics, Inc. (NASDAQ:PTCT) Position Decreased by Caption Management LLC | 9/10/2020
… shares of PTC Therapeutics by 92.9% in the first quarter. First Mercantile Trust Co. now owns 1,215 shares of the biopharmaceutical company’s stock worth $54,000 after buying an additional 585 shares during the period. Principal Financial Group Inc. boosted its holdings in shares of PTC Therapeutics by 4.1% in the first quarter. Principal Financial Group Inc. now owns 16,752 shares of the biopharmaceutical company’s stock worth $747,000 after buying an …
Cormorant Asset Management
Morgan Stanley Has $7.12 Million Position in AnaptysBio Inc (NASDAQ:ANAB) | 9/10/2020
… shares during the period. Morgan Stanley owned 1.85% of AnaptysBio worth $7,123,000 at the end of the most recent reporting period. A number of other hedge funds have also modified their holdings of ANAB. Cormorant Asset Management LP raised its position in shares of AnaptysBio by 203.5% in the 1st quarter. Cormorant Asset Management LP now owns 1,107,900 shares of the biotechnology company’s stock valued at $15,655,000 after buying an …
Boxer Capital
Investment company Boxer Capital, LLC ( Current Portfolio ) buys Principia Biopharma Inc, Amarin Corp PLC, Syndax Pharmaceuticals Inc, IDEAYA Biosciences Inc, DIREXION SH ETF TR, sells Regeneron Pharmaceuticals Inc, Immunomedics Inc, Arcus Biosciences Inc, Sage Therapeutics Inc, Axsome Therapeutics Inc during the 3-months ended 2020Q2, according to the most recent filings of the investment company, Boxer Capital, LLC. As of 2020Q2, Boxer Capital, LLC owns 63 stocks with a total …
Founders Fund
… board meeting appeared to have known about the defendants’ intentions. (Despite this, Weiden is not listed as a defendant in the suit.) On the other hand, the suit specifies that Ken Howery, who represented Founders Fund ‘s stake at the time, refused to support the board’s actions during the meeting. The success of this plan improved each defendant’s position at Zocdoc at the cost of Massoumi’s leadership position and the value …
Wells Fargo Securities
… outstanding common shares. The Company has not made a determination as to whether, or if so when, it will issue a notice of redemption for the 6% Subordinated Debentures due 2055. BofA Securities, Inc., Wells Fargo Securities , LLC and J.P. Morgan Securities LLC are joint book-running managers of the offering. This offering is being made pursuant to an effective shelf registration statement previously filed with the Securities and Exchange …
Y Combinator
… being led by Spark Capital and comes closely on the heels of Deel raising $14 million in a Series A only a few months ago led by Andreessen Horowitz. Deel is an alum of Y Combinator and counts the incubator, along with Nat Friedman, Ryan Petersen, John Zimmer, William Hockey and Alexis Ohanian, among its other investors. Deel has now raised some $48 million to date, and while Bouaziz said …
Cowen and Company
… 200 West Street, New York, New York 10282, via telephone: 866-471-2526, or via email: ; BofA Securities, Inc., Attention: Prospectus Department, NC1-004-03-43, 200 North College Street, 3rd Floor, Charlotte, NC 28255-0001, or by email at ; Cowen and Company , LLC, c/o Broadridge Financial Solutions, Attention: Prospectus Department, 1155 Long Island Avenue, Edgewood, NY 11717, by telephone at 833-297-2926, or by email at ; or Evercore Group L.L.C., Attention: Equity Capital Markets, 55 …
